approval · primary record
CANAKINUMAB
FDA · BLA · 2024-11-01
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2024-11-01 |
| Brand | ILARIS |
| Sponsor | NOVARTIS PHARMS |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:41.097Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CANAKINUMAB:2024-11-01
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.